NDC11 70748035501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70748-0355-01 | 70748-0355 |
| 70748-0355-1 | 70748-0355 |
| 70748-355-01 | 70748-355 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| rivaroxaban granule | RIVAROXABAN GRANULE | Lupin Pharmaceuticals, Inc. | b0306b06-d8cf-48de-9e93-57d77e4e98f5 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 70748-355-01 70748-355 70748035501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.